Skip to main content

We’ve updated our Terms & Conditions and Privacy Policy. By using this site, you agree to these terms.

Geisinger becomes the first member of Risant Health

People over 65, those with high-risk medical conditions can schedule online with MyGeisinger

Note: COVID-19 vaccine appointments are temporarily unavailable. If no appointments appear in MyGeisinger, there are currently none available. But check back often in MyGeisinger — we will open additional appointment slots as supplies and logistics allow.


DANVILLE, Pa.
– Geisinger is expanding the availability of COVID-19 vaccines to those who qualify as part of the state’s updated Phase 1A groups. Vaccine appointments are available at the health system’s community-based vaccine centers throughout central and northeastern Pennsylvania. 

Appointments are required to receive the vaccine, and can be made online using MyGeisinger. A questionnaire must be completed prior to scheduling to ensure eligibility and for health screening purposes. Those receiving the vaccine must bring to their appointments identification that verifies your eligibility as part of the state’s Phase 1A groups (certificate, license etc.) and a valid driver’s license.

If you’ve been cared for by Geisinger or have Geisinger Health Plan insurance, but don’t have a MyGeisinger account, you can create one online. Those who haven’t been cared for by Geisinger and don’t have Geisinger Health Plan insurance or anyone under the age of 18 can call 570-284-3657 for help setting up an account. 

In alignment with federal and state guidelines and as supplies, staffing and logistics allow, COVID vaccines will now also be available to those who qualify as part of the state’s Phase 1A groups.

Phase 1A groups now include:

  • Healthcare workers
  • People age 65 and older
  • People age 16–64 with high-risk medical conditions including:
  • Cancer
  • Chronic kidney disease
  • COPD
  • Down syndrome
  • Heart conditions (e.g., heart failure, coronary artery disease, cardiomyopathy)
  • Weakened immune system (from solid organ/blood/bone marrow transplant, immune deficiencies, HIV, use of corticosteroids or other immunity-weakening medicines)
  • Obesity (body mass index [BMI] of ≥30 kg/m2) or severe obesity (BMI ≥40 kg/m2)
  • Pregnancy
  • Sickle cell disease
  • Smoking
  • Type 2 diabetes

Geisinger is administering the Pfizer BioNTech and Moderna COVID vaccines. Due to the vaccine distribution process, it isn’t possible to select the vaccine you receive when scheduling your appointment. It’s important to remember that two doses of the vaccine are required, so it’s encouraged to consider both doses when scheduling. The second dose needs to be given between 26 and 30 days after the first. Scheduling for your second dose occurs at the time you receive the first dose at the vaccine center.

It’s required to receive both vaccine doses at the same location. Receiving that second dose is a critical step in the COVID vaccination process to trigger the immune response needed to develop an immunity level against COVID-19.

Vaccines also remain available to Geisinger staff and those in the state’s Tier 1A phase. To date, Geisinger has provided over 25,000 COVID-19 vaccine doses.

Even as the vaccine becomes more available in our communities, preventive measures to help stop the spread of the virus continue to be important. Everyone, including those who receive the vaccine, should continue to properly wear a mask, avoid group gatherings, maintain physical distancing and practice proper handwashing.

For answers to questions about the vaccine, visit the Geisinger COVID-19 vaccine resources center at geisinger.org/COVIDvax.

About Geisinger
Geisinger is among the nation’s leading providers of value-based care, serving 1.2 million people in urban and rural communities across Pennsylvania. Founded in 1915 by philanthropist Abigail Geisinger, the non-profit system generates $10 billion in annual revenues across 134 care sites - including 10 hospital campuses, and Geisinger Health Plan, with 600,000 members in commercial and government plans. The Geisinger College of Health Sciences educates more than 5,000 medical professionals annually and conducts more than 1,400 clinical research studies. With 26,000 employees, including 1,600 employed physicians, Geisinger is among Pennsylvania’s largest employers with an estimated economic impact of $14 billion to the state’s economy. On March 31, 2024, Geisinger became the first member of Risant Health, a new nonprofit charitable organization created to expand and accelerate value-based care across the country.  Learn more at geisinger.org or connect with us on Facebook, Instagram, LinkedIn and X.

 
geisinger placeholder

For media inquires:

Content from General Links with modal content